PKCη Recombinant Rabbit Monoclonal Antibody: A Precision Tool for Unraveling Cell Signaling Networks

1. Concept

Protein kinase C η (PKCη), a key member of the protein kinase C family, serves as a critical node in diverse cellular signaling pathways. It plays multifaceted roles in physiological and pathological processes, including epithelial cell differentiation, immune regulation, tumorigenesis, and neural function. The study of PKCη has long been hindered by limitations of traditional antibody tools. However, the advent of recombinant rabbit monoclonal antibody technology has revolutionized this field, enabling precise detection of PKCη’s expression, activation state, and subcellular localization. ANT BIO PTE. LTD.’s PKCη Recombinant Rabbit Monoclonal Antibody (Catalog No.: S0B0790) stands out as a high-performance research tool, addressing the shortcomings of conventional antibodies and empowering in-depth exploration of PKCη-mediated signaling mechanisms.

2. Research Frontiers

2.1 Limitations of Traditional Antibodies in PKCη Research

Prior to the maturity of recombinant rabbit monoclonal antibody technology, PKCη research relied primarily on traditional polyclonal antibodies or murine monoclonal antibodies, both of which suffer from inherent drawbacks:

·       Polyclonal Antibodies: Derived from immunized animal serum, these antibodies target multiple epitopes, leading to high cross-reactivity. Due to significant sequence homology among PKC family members (especially in the catalytic domain), polyclonal antibodies against PKCη often cross-react with isoforms like PKCδ and PKCε. This results in nonspecific bands in Western Blot (WB) and high background noise in Immunohistochemistry (IHC), compromising experimental specificity and signal-to-noise ratio.

·       Murine Monoclonal Antibodies: Produced via hybridoma technology, these antibodies mitigate batch-to-batch variability but are limited by the murine immune system’s ability to generate high-affinity antibodies against conserved proteins like PKCη. Additionally, species differences may lead to insufficient sensitivity or nonspecific binding in human tissue samples, making it challenging to detect subtle changes in PKCη expression or subcellular localization during complex biological processes.

2.2 Superior Performance of Recombinant Rabbit Monoclonal Antibody Technology

Recombinant rabbit monoclonal antibody technology represents a breakthrough in antibody engineering, combining the advantages of the rabbit immune system with recombinant DNA techniques (e.g., phage display, single B-cell cloning) to produce high-quality research tools.

The technical workflow involves: (1) Immunizing rabbits with highly purified PKCη antigens (e.g., recombinant proteins or functional domain peptides). Rabbits possess a diverse antibody gene repertoire and excel at generating high-affinity antibodies against conserved proteins. (2) Isolating B lymphocytes from immunized rabbits and cloning the variable region genes of light and heavy chains. (3) Expressing these genes in mammalian cells (e.g., HEK293) via recombinant vectors, bypassing traditional hybridoma technology for full process control.

Key advantages of this technology include:

·       Exceptional Specificity and Affinity: Rigorous screening and validation ensure antibodies specifically recognize unique PKCη epitopes, minimizing cross-reactivity with other PKC isoforms.

·       Unmatched Batch Consistency: Production based on fixed DNA sequences guarantees consistent performance across batches, enabling long-term comparability and reproducibility of experimental results.

·       Broad Applicability: These antibodies perform reliably across multiple platforms, including WB, Immunoprecipitation (IP), Chromatin Immunoprecipitation (ChIP), Immunofluorescence (IF), and IHC. Their high affinity facilitates clear signal detection even in challenging samples (e.g., paraffin-embedded tissues).

2.3 Key Research Areas Enabled by PKCη Recombinant Rabbit Monoclonal Antibody

ANT BIO PTE. LTD.’s PKCη Recombinant Rabbit Monoclonal Antibody has become an indispensable tool in cutting-edge research, driving advancements in multiple fields:

·       Cancer Biology: PKCη exhibits abnormal expression in epithelial-derived tumors, functioning as either an oncogene or tumor suppressor depending on the context. The antibody enables accurate quantification of PKCη expression and subcellular localization (cytoplasmic, nuclear, or membrane) in tumor tissues of different stages/grades, correlating these with clinical-pathological features and patient prognosis. This supports the exploration of PKCη as a potential biomarker or therapeutic target.

·       Cell Signaling Network Analysis: PKCη acts as a key node in downstream pathways of GPCRs and RTKs. Through IP-mass spectrometry (IP-MS), the antibody captures PKCη-interacting protein complexes, mapping dynamic signaling networks and uncovering novel regulatory mechanisms. Confocal-based dual-label IF allows real-time observation of PKCη’s spatiotemporal dynamics under growth factor stimulation, drug treatment, or stress, visualizing its activation/inactivation processes.

·       Neuroscience and Immune Regulation: The antibody’s high sensitivity enables precise quantification and localization of PKCη in low-abundance samples (e.g., brain tissue sections, primary immune cells), facilitating research into its roles in neural development, synaptic plasticity, and immune cell activation/differentiation.

·       Epithelial Biology and Inflammation: The antibody supports studies on PKCη’s role in epithelial cell differentiation, skin barrier function, and inflammatory responses, providing insights into diseases linked to epithelial dysfunction or aberrant inflammation.

3. Research Significance

The development and application of PKCη recombinant rabbit monoclonal antibodies address long-standing technical barriers in PKCη research. By enabling precise, specific detection of PKCη, these tools deepen our understanding of its biological functions and signaling mechanisms across diverse physiological and pathological contexts. This research not only advances basic science but also accelerates translational studies—identifying PKCη as a potential biomarker for disease diagnosis/prognosis and a therapeutic target for cancer, inflammatory disorders, and neurodegenerative diseases. Additionally, the antibody’s versatility and reliability support interdisciplinary research, fostering collaboration across cell biology, immunology, oncology, and neuroscience.

4. Related Mechanisms, Research Methods, and Product Applications

4.1 Related Mechanisms

PKCη mediates cellular responses by integrating upstream signals (e.g., LPS, growth factors) and activating downstream pathways such as p38 MAPK, ERK1/2, and MBD2-mediated demethylation. These pathways regulate key processes including inflammation (iNOS, Cox2 expression), apoptosis, epithelial differentiation, and immune cell function. Dysregulation of PKCη signaling contributes to diseases such as cancer, inflammatory disorders, and neurodegeneration.

4.2 Research Methods

Key methods leveraging the PKCη antibody include:

·       Protein Detection and Localization: WB for quantifying PKCη expression; IF/IHC for visualizing subcellular localization and tissue distribution.

·       Protein-Protein Interaction Analysis: IP, Co-IP, and IP-MS to identify PKCη-interacting partners and map signaling networks.

·       Functional Assays: Combined with cell stimulation (e.g., LPS, growth factors) or gene manipulation (knockdown/overexpression) to study PKCη’s role in cell proliferation, differentiation, apoptosis, and inflammation.

·       Translational Research: Tissue microarray analysis and clinical sample screening to correlate PKCη expression with disease outcomes.

4.3 Product Applications

ANT BIO PTE. LTD.’s PKCη Recombinant Rabbit Monoclonal Antibody (Catalog No.: S0B0790) is applicable to:

·       Studies on epithelial cell differentiation, skin barrier function, and inflammatory responses.

·       Exploration of PKCη’s role in tumorigenesis and epithelial-mesenchymal transition (EMT).

·       Analysis of PKCη-mediated signaling pathways in immune cells, neurons, and epithelial cells.

·       Development of diagnostic tools for diseases linked to PKCη dysregulation.

·       Validation of PKCη as a therapeutic target in preclinical studies.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering global life science research and pharmaceutical innovation by delivering high-quality, reliable biological reagents and comprehensive solutions. Leveraging advanced development platforms—including recombinant antibody technology (rabbit/mouse monoclonal), protein expression systems (E.coli, CHO, HEK293, Insect Cells), and One-Step ELISA platforms—we adhere to stringent international certifications (EU 98/79/EC, ISO9001, ISO13485) to ensure product excellence. Our mission is to support researchers and drug developers in unraveling disease mechanisms, accelerating therapeutic breakthroughs, and ultimately advancing human health.

6. Related Product List

Core Product Advantages

·       High Specificity and Subcellular Localization Detection: Precisely recognizes PKCη, with clear cytoplasmic and perinuclear localization in epithelial cells, low background, and distinct signals—ideal for studying PKCη expression and function.

·       Exceptional Stability and Batch Consistency: Manufactured under strict quality control, ensuring robust physicochemical stability and minimal batch-to-batch variation for reliable, reproducible experimental results.

·       Multi-Platform Validation: Rigorously validated for WB, IF, and IP applications, providing versatility across cell biology, immunology, and translational research.

Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.